Paics, a De Novo Purine Synthetic Enzyme, Is a Novel Target for AML Therapy
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-127047
Abstract: Progress has been made in deciphering molecular mechanisms underlying AML pathogenesis due in part to near-complete understanding of AML genomes. However, AML is yet a devastating disease with a long-term survival rate of less than… read more here.
Keywords: paicsi; cell lines; crispr cas9; aml ... See more keywords